NeuroOne Medical Technologies financials at a glance

+ Portfolio

The revenue of NeuroOne Medical Technologies is reported as 0.00341 billion Dollars in the fiscal year 2023. The earnings were -0.65 Dollars per share in 2023, which was 3.17 lower than 2022. And about -0.00038 billion Dollars are reported as free cash flow in the financials of NeuroOne Medical Technologies 2023. No dividends were paid to the shareholders of the NeuroOne Medical Technologies stock NasdaqCM:NMTC in the financial year 2023.

$3.41M

Revenue

$-0.65

Earnings Per Share

-,147.58%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

3.41

Earnings Per Share

-0.65

Gross Margin %

-,147.58

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022	2021
Rev.	Revenue	N/A	$3.41M	$2.12M	$0.24M
GM %	Gross Margin %	-,147.58%	-,147.58%	-,143.93%	-13.56%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-0.65	$-0.65	$-0.63	$-0.93
Div.	Dividends	N/A	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0
Sha.	Shares	N/AM	23.96M	16.24M	16.19M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M	$-8.60M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M	$-8.67M
FCFS	Free Cash Flow Per Share	$0.00	$-0.73	$-0.49	$-0.81

NeuroOne Medical Technologies financials at a glance

Financials

Discover